oseltamivir has been researched along with d-alpha tocopherol in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Galabov, AS; Gegova, G; Mileva, M; Simeonova, L | 1 |
| Pavlova, EL; Simeonova, LS; Zografov, NN | 1 |
1 review(s) available for oseltamivir and d-alpha tocopherol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
2 other study(ies) available for oseltamivir and d-alpha tocopherol
| Article | Year |
|---|---|
Combination activity of neuraminidase inhibitor oseltamivir and α-tocopherol in influenza virus A (H3N2) infection in mice.
Topics: Administration, Oral; alpha-Tocopherol; Animals; Dogs; Dose-Response Relationship, Drug; Enzyme Inhibitors; Influenza A Virus, H3N2 Subtype; Madin Darby Canine Kidney Cells; Male; Mice; Mice, Inbred ICR; Microbial Sensitivity Tests; Neuraminidase; Orthomyxoviridae Infections; Oseltamivir; Structure-Activity Relationship | 2015 |
Comparative study on the antioxidant capacities of synthetic influenza inhibitors and ellagic acid in model systems.
Topics: Antioxidants; Antiviral Agents; Ascorbic Acid; Ellagic Acid; Hydrogen Peroxide; Inosine Pranobex; Iron; Kinetics; Luminescent Measurements; Models, Biological; NAD; Oseltamivir; Oxidation-Reduction; Reference Standards; Vitamin E | 2016 |